Michael A. Rossi

CIK 1783869 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 3, 2023 · Latest: Jan. 3, 2023

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 22 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Dec. 29, 2022 HBIO F 3,035 $2.55 $7,739 260,540 Direct -1.15% Disposed -72.3% (price as of 2026-08-19)
Dec. 29, 2022 HBIO F 3,763 $2.55 $9,596 263,575 Direct -1.41% Disposed -72.3% (price as of 2026-08-19)
Dec. 29, 2022 HBIO F 3,162 $2.55 $8,063 267,338 Direct -1.17% Disposed -72.3% (price as of 2026-08-19)
July 18, 2022 HBIO F 7,008 $3.63 $25,439 270,500 Direct -2.53% Disposed -80.6% (price as of 2026-08-19)
June 11, 2022 HBIO F 6,325 $3.95 $24,984 277,508 Direct -2.23% Disposed -82.1% (price as of 2026-08-19)
March 1, 2022 HBIO A 28,716 — — 283,833 Direct +11.26% Acquired (price as of 2026-08-19)
March 1, 2022 HBIO A 31,021 — — 255,117 Direct +13.84% Acquired (price as of 2026-08-19)
Dec. 29, 2021 HBIO F 3,763 $7.27 $27,357 224,096 Direct -1.65% Disposed -90.3% (price as of 2026-08-19)
Dec. 29, 2021 HBIO F 3,163 $7.27 $22,995 227,859 Direct -1.37% Disposed -90.3% (price as of 2026-08-19)
July 18, 2021 HBIO F 6,966 $7.57 $52,733 231,022 Direct -2.93% Disposed -90.7% (price as of 2026-08-19)
June 11, 2021 HBIO F 6,172 $7.64 $47,154 237,988 Direct -2.53% Disposed -90.8% (price as of 2026-08-19)
June 11, 2021 HBIO A 21,546 — — 244,160 Direct +9.68% Acquired (price as of 2026-08-19)
March 1, 2021 HBIO A 36,876 — — 222,614 Direct +19.85% Acquired (price as of 2026-08-19)
March 1, 2021 HBIO A 38,462 — — 185,738 Direct +26.12% Acquired (price as of 2026-08-19)
Dec. 31, 2020 HBIO F 3,744 $4.29 $16,062 147,276 Direct -2.48% Disposed -83.6% (price as of 2026-08-19)
July 18, 2020 HBIO A 23,877 — — 157,814 Direct +17.83% Acquired (price as of 2026-08-19)
July 18, 2020 HBIO F 6,794 $3.42 $23,235 151,020 Direct -4.31% Disposed -79.4% (price as of 2026-08-19)
June 11, 2020 HBIO A 43,092 — — 90,845 Direct +90.24% Acquired (price as of 2026-08-19)
June 11, 2020 HBIO A 43,092 — — 133,937 Direct +47.43% Acquired (price as of 2026-08-19)
June 11, 2020 HBIO A 92,896 — — 92,896 Direct — Acquired (price as of 2026-08-19)
July 18, 2019 HBIO A 111,842 — — 111,842 Direct — Acquired (price as of 2026-08-19)
July 18, 2019 HBIO A 47,753 — — 47,753 Direct — Acquired (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 11, 2020 HBIO Stock option (right to buy) Common Stock (92,896) $2.63 June 11, 2027 92,896 Acquired
July 18, 2019 HBIO Stock option (right to buy) Common Stock, par value $0.01 per share (111,842) $1.78 July 18, 2029 111,842 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

HBIO

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2022 $340,000 — — — — — — $682,746
2021 $340,000 — $340,000 — $115,600 — $23,150 $818,750
2020 $340,000 $63,798 $241,752 $113,333 — — $19,278 $778,161

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.